Home/Cyclerion Therapeutics/Errol De Souza, PhD
ED

Errol De Souza, PhD

Chairman of the Board of Directors

Cyclerion Therapeutics

Cyclerion Therapeutics Pipeline

DrugIndicationPhase
CYC-126Treatment-Resistant Depression (TRD)Phase 2